CFDE Data Portal | Search PAIP1P1

	Label	Description
	PAIP1P1 associations Collection (Entity type)	Associations for PAIP1P1_associations
	PAIP1P1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	PAIP1P1 Gene (Entity type)	ENSG00000233892 - PAIP1 pseudogene 1
	GSE199538 GSE199539 enzalutamide 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE122979 GSE122980 LCL-161 MCF-7 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE209698 calcitriol D 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 14 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE164874 prednisolone muscle organ 5 v 13 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE112202 digoxin 5 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE165548 gemcitabine 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS

PAIP1P1 associations

Associations for PAIP1P1_associations

PAIP1P1 associations.tsv

A file from IDG as part of the Harmonizome project

PAIP1P1

ENSG00000233892 - PAIP1 pseudogene 1

GSE199538 GSE199539 enzalutamide 2 v 1 human dn

A Gene Set from LINCS

GSE122979 GSE122980 LCL-161 MCF-7 2 v 0 human up

A Gene Set from LINCS

GSE209698 calcitriol D 2 v 1 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 14 v 6 human up

A Gene Set from LINCS

GSE164874 prednisolone muscle organ 5 v 13 human dn

A Gene Set from LINCS

GSE112202 digoxin 5 v 2 human dn

A Gene Set from LINCS

GSE165548 gemcitabine 2 v 4 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.